Kent Rogers

Kent Rogers currently serves as the Chief Executive Officer of EveryONE Medicines, a position held since July 2024. Additionally, Kent is a Board Member at SlateRx and a Venture Partner at ARCH Venture Partners, contributing to investments in disruptive science companies. Previously, Kent held key roles including Chief Commercial Officer at EQRx, Senior Vice President and Chief Industry Relations Officer at Optum, and Vice President of Global Market Access at Acorda Therapeutics. Kent's career spans over 30 years in the pharmaceutical and biotechnology sectors, demonstrating extensive expertise in strategic commercialization, market access, and industry relations. Educational qualifications include an MBA in International Business from Emory University's Goizueta Business School and a Bachelor of Science in Business Management and Organizational Change from Indiana University Bloomington.